Allopurinol to lower heart and stroke risks in high-risk people
Treatments studied
Part of Heart & circulation clinical trials.
This trial studies whether allopurinol can reduce the chance of cardiovascular events like heart attack, stroke, or related problems in people who are at higher risk. It targets people with higher uric acid and other risk factors, to see if lowering uric acid helps protect the heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 40 and 70 years old.
- Have signed consent to join the study.
- Have a uric acid level above 5 mg/dL in blood tests within the last 6 months.
- Be at high cardiovascular risk (for example, higher 10-year risk score, known heart/brain blood vessel disease, atrial fibrillation, heart failure in early stages, peripheral artery disease, or diabetes/high blood pressure with organ damage signs).
- Not currently take allopurinol, febuxostat, or any other uric-acid–lowering medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This trial tests whether a special probiotic supplement combined with an enzyme can help lower uric acid levels in your blood. High uric acid can cause gout and kidney problems, so this treatment may help prevent those conditions.
This trial tests whether people with well-controlled gout can safely stop their urate-lowering medication (allopurinol or febuxostat) if an ultrasound shows no urate crystals in their joints. It may help you avoid unnecessary medication while keeping your gout under control.
This trial checks if testing for a specific gene (HLA-B*58:01) before starting gout medication can prevent severe allergic reactions. It compares standard care with a gene-guided approach to see which is safer and works better.
This trial tests a new tablet (HR091506) for adults with gout and high uric acid. It aims to lower uric acid levels and reduce gout attacks, especially for people with more severe gout (like tophi or frequent attacks).
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.